<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2025//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_250101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">35320699</PMID><DateCompleted><Year>2022</Year><Month>06</Month><Day>16</Day></DateCompleted><DateRevised><Year>2025</Year><Month>03</Month><Day>08</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1947-5446</ISSN><JournalIssue CitedMedium="Internet"><Volume>13</Volume><PubDate><Year>2022</Year><Month>Jun</Month><Day>10</Day></PubDate></JournalIssue><Title>Annual review of chemical and biomolecular engineering</Title><ISOAbbreviation>Annu Rev Chem Biomol Eng</ISOAbbreviation></Journal><ArticleTitle>Nanotherapeutics and the Brain.</ArticleTitle><Pagination><StartPage>325</StartPage><EndPage>346</EndPage><MedlinePgn>325-346</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1146/annurev-chembioeng-092220-030853</ELocationID><Abstract><AbstractText>Brain disease remains a significant health, social, and economic burden with a high failure rate of translation of therapeutics to the clinic. Nanotherapeutics have represented a promising area of technology investment to improve drug bioavailability and delivery to the brain, with several successes for nanotherapeutic use for central nervous system disease that are currently in the clinic. However, renewed and continued research on the treatment of neurological disorders is critically needed. We explore the challenges of drug delivery to the brain and the ways in which nanotherapeutics can overcome these challenges. We provide a summary and overview of general design principles that can be applied to nanotherapeutics for uptake and penetration in the brain. We next highlight remaining questions that limit the translational potential of nanotherapeutics for application in the clinic. Lastly, we provide recommendations for ongoing preclinical research to improve the overall success of nanotherapeutics against neurological disease.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Joseph</LastName><ForeName>Andrea</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Obstetrics and Gynecology, University of Pennsylvania, Philadelphia, Pennsylvania, USA; email: aajoseph@upenn.edu.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nance</LastName><ForeName>Elizabeth</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Department of Chemical Engineering, University of Washington, Seattle, Washington, USA; email: eanance@uw.edu.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>P30 ES007033</GrantID><Acronym>ES</Acronym><Agency>NIEHS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R35 GM124677</GrantID><Acronym>GM</Acronym><Agency>NIGMS NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType><PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>03</Month><Day>23</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Annu Rev Chem Biomol Eng</MedlineTA><NlmUniqueID>101574034</NlmUniqueID><ISSNLinking>1947-5438</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D001921" MajorTopicYN="N">Brain</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016503" MajorTopicYN="N">Drug Delivery Systems</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D050997" MajorTopicYN="N">Nanomedicine</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D053758" MajorTopicYN="Y">Nanoparticles</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009422" MajorTopicYN="Y">Nervous System Diseases</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">blood&#x2013;brain barrier</Keyword><Keyword MajorTopicYN="N">brain delivery</Keyword><Keyword MajorTopicYN="N">brain distribution</Keyword><Keyword MajorTopicYN="N">brain parenchyma</Keyword><Keyword MajorTopicYN="N">nanomedicine</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>3</Month><Day>24</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>6</Month><Day>18</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>3</Month><Day>23</Day><Hour>20</Hour><Minute>5</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2022</Year><Month>6</Month><Day>27</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">35320699</ArticleId><ArticleId IdType="mid">NIHMS1816358</ArticleId><ArticleId IdType="pmc">PMC9236656</ArticleId><ArticleId IdType="doi">10.1146/annurev-chembioeng-092220-030853</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>van Middendorp JJ, Sanchez GM, Burridge AL. 2010. The Edwin Smith papyrus: a clinical reappraisal of the oldest known document on spinal injuries. Eur. Spine J 19:1815&#x2013;23</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2989268</ArticleId><ArticleId IdType="pubmed">20697750</ArticleId></ArticleIdList></Reference><Reference><Citation>Finger S 2005. Minds Behind the Brain: A History of the Pioneers and Their Discoveries. Oxford, UK: Oxford Univ. Press</Citation></Reference><Reference><Citation>Lackland DT, Roccella EJ, Deutsch AF, Fornage M, George MG, et al. 2014. Factors influencing the decline in stroke mortality: a statement from the American Heart Association/American Stroke Association. Stroke 45:315&#x2013;53</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5995123</ArticleId><ArticleId IdType="pubmed">24309587</ArticleId></ArticleIdList></Reference><Reference><Citation>Wingerchuk DM, Carter JL. 2014. Multiple sclerosis: current and emerging disease-modifying therapies and treatment strategies. Mayo Clin. Proc 89:225&#x2013;40</Citation><ArticleIdList><ArticleId IdType="pubmed">24485135</ArticleId></ArticleIdList></Reference><Reference><Citation>UN Dep. Econ. Soc. Aff. Popul. Div. 2019. World population ageing 2019: highlights. Publ., ST/ESA/SER.A/430, United Nat., New York</Citation></Reference><Reference><Citation>Robinson MD. 2019. The Market in Mind: How Financialization Is Shaping Neuroscience, Translational Medicine, and Innovation in Biotechnology. Cambridge, MA: MIT Press</Citation></Reference><Reference><Citation>Pankevich DE, Altevogt BM, Dunlop J, Gage FH, Hyman SE. 2014. Improving and accelerating drug development for nervous system disorders. Neuron 84:546&#x2013;53</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4254615</ArticleId><ArticleId IdType="pubmed">25442933</ArticleId></ArticleIdList></Reference><Reference><Citation>Randall TS, Sam C, Tartar A, Murray P, Cannon C. 2021. More than 6.59 billion shots given: COVID-19 tracker. Bloomberg, Nov. 4</Citation></Reference><Reference><Citation>Mikulic M
2021. COVID-19 vaccinations administered in the U.S. as of October 2021, by manufacturer. Statista, Nov. 4. https://www.statista.com/statistics/1198516/covid-19-vaccinations-administered-us-by-company/</Citation></Reference><Reference><Citation>Yang G, Liu Y, Wang H, Wilson R, Hui Y, et al. 2019. Bioinspired core&#x2013;shell nanoparticles for hydrophobic drug delivery. Angew. Chem 131:14495&#x2013;502</Citation><ArticleIdList><ArticleId IdType="pubmed">31364258</ArticleId></ArticleIdList></Reference><Reference><Citation>Owens DE 3rd, Peppas NA. 2006. Opsonization, biodistribution, and pharmacokinetics of polymeric nanoparticles. Int. J. Pharm 307:93&#x2013;102</Citation><ArticleIdList><ArticleId IdType="pubmed">16303268</ArticleId></ArticleIdList></Reference><Reference><Citation>Biedl A, Kraus R. 1898. &#xdc;ber eine bisher unbekannte toxische Wirkung der Gallens&#xe4;uren auf das Zentralnervensystem. Centralblatt. Inn. Med 19:1185&#x2013;200</Citation></Reference><Reference><Citation>Lewandowsky M 1909. Zur lehre der cerebrospinalflussigkeit. Z. Klin. Med 40:480&#x2013;94</Citation></Reference><Reference><Citation>Ribatti D, Nico B, Crivellato E, Artico M. 2006. Development of the blood-brain barrier: a historical point of view. Anat. Rec. B 289:3&#x2013;8</Citation><ArticleIdList><ArticleId IdType="pubmed">16437552</ArticleId></ArticleIdList></Reference><Reference><Citation>Bors LA, Erd&#x151; F. 2019. Overcoming the blood&#x2013;brain barrier. Challenges and tricks for CNS drug delivery. Sci. Pharm 87:6</Citation></Reference><Reference><Citation>Pardridge WM. 2005. The blood-brain barrier: bottleneck in brain drug development. NeuroRx 2:3&#x2013;14</Citation><ArticleIdList><ArticleId IdType="pmc">PMC539316</ArticleId><ArticleId IdType="pubmed">15717053</ArticleId></ArticleIdList></Reference><Reference><Citation>Pardridge WM. 2012. Drug transport across the blood-brain barrier. J. Cereb. Blood Flow Metab 32:1959&#x2013;72</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3494002</ArticleId><ArticleId IdType="pubmed">22929442</ArticleId></ArticleIdList></Reference><Reference><Citation>Profaci CP, Munji RN, Pulido RS, Daneman R. 2020. The blood-brain barrier in health and disease: important unanswered questions. J. Exp. Med 217:e20190062.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7144528</ArticleId><ArticleId IdType="pubmed">32211826</ArticleId></ArticleIdList></Reference><Reference><Citation>Dityatev A, Seidenbecher CI, Schachner M. 2010. Compartmentalization from the outside: the extracellular matrix and functional microdomains in the brain. Trends Neurosci. 33:503&#x2013;12</Citation><ArticleIdList><ArticleId IdType="pubmed">20832873</ArticleId></ArticleIdList></Reference><Reference><Citation>Logsdon AF, Rhea EM, Reed M, Banks WA, Erickson MA. 2021. The neurovascular extracellular matrix in health and disease. Exp. Biol. Med 246:835&#x2013;44</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8719034</ArticleId><ArticleId IdType="pubmed">33302738</ArticleId></ArticleIdList></Reference><Reference><Citation>Bruckner G, Hartig W, Kacza J, Seeger J, Welt K, Brauer K. 1996. Extracellular matrix organization in various regions of rat brain grey matter. J. Neurocytol 25:333&#x2013;46</Citation><ArticleIdList><ArticleId IdType="pubmed">8818977</ArticleId></ArticleIdList></Reference><Reference><Citation>Benarroch EE. 2015. Extracellular matrix in the CNS: dynamic structure and clinical correlations. Neurology 85:1417&#x2013;27</Citation><ArticleIdList><ArticleId IdType="pubmed">26400579</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim TW, Kim Y, Jung W, Kim DE, Keum H, et al. 2021. Bilirubin nanomedicine ameliorates the progression of experimental autoimmune encephalomyelitis by modulating dendritic cells. J. Control. Release 331:74&#x2013;84</Citation><ArticleIdList><ArticleId IdType="pubmed">33450316</ArticleId></ArticleIdList></Reference><Reference><Citation>de la Flor R, Robertson J, Shevchenko RV, Alavijeh M, Bickerton S, et al. 2021. Multiple sclerosis: LIFNano-CD4 for Trojan Horse delivery of the neuro-protective biologic &#x201c;LIF&#x201d; into the brain: preclinical proof of concept. Front. Med. Technol 3. 10.3389/fmedt.2021.640569</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmedt.2021.640569</ArticleId><ArticleId IdType="pmc">PMC8757767</ArticleId><ArticleId IdType="pubmed">35047909</ArticleId></ArticleIdList></Reference><Reference><Citation>Heckman KL, DeCoteau W, Estevez A, Reed KJ, Costanzo W, et al. 2013. Custom cerium oxide nanoparticles protect against a free radical mediated autoimmune degenerative disease in the brain. ACS Nano 7:10582&#x2013;96</Citation><ArticleIdList><ArticleId IdType="pubmed">24266731</ArticleId></ArticleIdList></Reference><Reference><Citation>Pei W, Wan X, Shahzad KA, Zhang L, Song S, et al. 2018. Direct modulation of myelin-autoreactive CD4+ and CD8+ T cells in EAE mice by a tolerogenic nanoparticle co-carrying myelin peptide-loaded major histocompatibility complexes, CD47 and multiple regulatory molecules. Int. J. Nanomed 13:3731&#x2013;50</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6027825</ArticleId><ArticleId IdType="pubmed">29983566</ArticleId></ArticleIdList></Reference><Reference><Citation>Carnasciali A, Amoriello R, Bonechi E, Mazzoni A, Ravagli C, et al. 2021. T cell delivery of nanoparticles-bound anti-CD20 monoclonal antibody: successful B cell depletion in the spinal cord during experimental autoimmune encephalomyelitis. J. Neuroimmune Pharmacol 16:376&#x2013;89</Citation><ArticleIdList><ArticleId IdType="pubmed">32514635</ArticleId></ArticleIdList></Reference><Reference><Citation>Casey LM, Pearson RM, Hughes KR, Liu JMH, Rose JA, et al. 2018. Conjugation of transforming growth factor beta to antigen-loaded poly(lactide-co-glycolide) nanoparticles enhances efficiency of antigen-specific tolerance. Bioconjug. Chem 29:813&#x2013;23</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6850215</ArticleId><ArticleId IdType="pubmed">29148731</ArticleId></ArticleIdList></Reference><Reference><Citation>Hunter Z, McCarthy DP, Yap WT, Harp CT, Getts DR, et al. 2014. A biodegradable nanoparticle platform for the induction of antigen-specific immune tolerance for treatment of autoimmune disease. ACS Nano 8:2148&#x2013;60</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3990004</ArticleId><ArticleId IdType="pubmed">24559284</ArticleId></ArticleIdList></Reference><Reference><Citation>Sharma R, Kambhampati SP, Zhang Z, Sharma A, Chen S, et al. 2020. Dendrimer mediated targeted delivery of sinomenine for the treatment of acute neuroinflammation in traumatic brain injury. J. Control. Release 323:361&#x2013;75</Citation><ArticleIdList><ArticleId IdType="pubmed">32339548</ArticleId></ArticleIdList></Reference><Reference><Citation>Kumthekar P, Ko CH, Paunesku T, Dixit K, Sonabend AM, et al. 2021. A first-in-human phase 0 clinical study of RNA interference-based spherical nucleic acids in patients with recurrent glioblastoma. Sci. Transl. Med 13:eabb3945.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8272521</ArticleId><ArticleId IdType="pubmed">33692132</ArticleId></ArticleIdList></Reference><Reference><Citation>Curley CT, Mead BP, Negron K, Kim N, Garrison WJ, et al. 2020. Augmentation of brain tumor interstitial flow via focused ultrasound promotes brain-penetrating nanoparticle dispersion and transfection. Sci. Adv 6:eaay1344.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7195188</ArticleId><ArticleId IdType="pubmed">32494662</ArticleId></ArticleIdList></Reference><Reference><Citation>Fisher DG, Price RJ. 2019. Recent advances in the use of focused ultrasound for magnetic resonance image-guided therapeutic nanoparticle delivery to the central nervous system. Front. Pharmacol 10:1348.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6864822</ArticleId><ArticleId IdType="pubmed">31798453</ArticleId></ArticleIdList></Reference><Reference><Citation>Carpentier A, Canney M, Vignot A, Reina V, Beccaria K, et al. 2016. Clinical trial of blood-brain barrier disruption by pulsed ultrasound. Sci. Transl. Med 8:343re2</Citation><ArticleIdList><ArticleId IdType="pubmed">27306666</ArticleId></ArticleIdList></Reference><Reference><Citation>Idbaih A, Canney M, Belin L, Desseaux C, Vignot A, et al. 2019. Safety and feasibility of repeated and transient blood-brain barrier disruption by pulsed ultrasound in patients with recurrent glioblastoma. Clin. Cancer Res 25:3793&#x2013;801</Citation><ArticleIdList><ArticleId IdType="pubmed">30890548</ArticleId></ArticleIdList></Reference><Reference><Citation>Lipsman N, Meng Y, Bethune AJ, Huang Y, Lam B, et al. 2018. Blood-brain barrier opening in Alzheimer&#x2019;s disease using MR-guided focused ultrasound. Nat. Commun 9:2336.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6060168</ArticleId><ArticleId IdType="pubmed">30046032</ArticleId></ArticleIdList></Reference><Reference><Citation>Mainprize T, Lipsman N, Huang Y, Meng Y, Bethune A, et al. 2019. Blood-brain barrier opening in primary brain tumors with non-invasive MR-guided focused ultrasound: a clinical safety and feasibility study. Sci. Rep 9:321.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6344541</ArticleId><ArticleId IdType="pubmed">30674905</ArticleId></ArticleIdList></Reference><Reference><Citation>Joseph A, Wood T, Chen C-C, Corry K, Snyder JM, et al. 2018. Curcumin-loaded polymeric nanoparticles for neuroprotection in neonatal rats with hypoxic-ischemic encephalopathy. Nano Res. 11:5670&#x2013;88</Citation></Reference><Reference><Citation>Joseph A, Nyambura CW, Bondurant D, Corry K, Beebout D, et al. 2021. Formulation and efficacy of catalase-loaded nanoparticles for the treatment of neonatal hypoxic-ischemic encephalopathy. Pharmaceutics 13:1131.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8400001</ArticleId><ArticleId IdType="pubmed">34452092</ArticleId></ArticleIdList></Reference><Reference><Citation>Kulikova OI, Berezhnoy DS, Stvolinsky SL, Lopachev AV, Orlova VS, Fedorova TN. 2018. Neuroprotective effect of the carnosine&#x2013;&#x3b1;-lipoic acid nanomicellar complex in a model of early-stage Parkinson&#x2019;s disease. Regul. Toxicol. Pharmacol 95:254&#x2013;59</Citation><ArticleIdList><ArticleId IdType="pubmed">29601911</ArticleId></ArticleIdList></Reference><Reference><Citation>Hashemian M, Ghasemi-Kasman M, Ghasemi S, Akbari A, Moalem-Banhangi M, et al. 2019. Fabrication and evaluation of novel quercetin-conjugated Fe3O4-&#x3b2;-cyclodextrin nanoparticles for potential use in epilepsy disorder. Int. J. Nanomed 14:6481&#x2013;95</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6698168</ArticleId><ArticleId IdType="pubmed">31496698</ArticleId></ArticleIdList></Reference><Reference><Citation>Del Grosso A, Galliani M, Angella L, Santi M, Tonazzini I, et al. 2019. Brain-targeted enzyme-loaded nanoparticles: a breach through the blood-brain barrier for enzyme replacement therapy in Krabbe disease. Sci. Adv 5:eaax7462.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6867879</ArticleId><ArticleId IdType="pubmed">31799395</ArticleId></ArticleIdList></Reference><Reference><Citation>Joshi HP, Kumar H, Choi UY, Lim YC, Choi H, et al. 2020. CORM-2-solid lipid nanoparticles maintain integrity of blood-spinal cord barrier after spinal cord injury in rats. Mol. Neurobiol 57:2671&#x2013;89</Citation><ArticleIdList><ArticleId IdType="pubmed">32300934</ArticleId></ArticleIdList></Reference><Reference><Citation>Mo Y, Duan L, Yang Y, Liu W, Zhang Y, et al. 2021. Nanoparticles improved resveratrol brain delivery and its therapeutic efficacy against intracerebral hemorrhage. Nanoscale 13:3827&#x2013;40</Citation><ArticleIdList><ArticleId IdType="pubmed">33565555</ArticleId></ArticleIdList></Reference><Reference><Citation>Mittal G, Carswell H, Brett R, Currie S, Kumar MN. 2011. Development and evaluation of polymer nanoparticles for oral delivery of estradiol to rat brain in a model of Alzheimer&#x2019;s pathology. J. Control. Release 150(2):220&#x2013;28</Citation><ArticleIdList><ArticleId IdType="pubmed">21111014</ArticleId></ArticleIdList></Reference><Reference><Citation>So PW, Ekonomou A, Galley K, Brody L, Sahuri-Arisoylu M, et al. 2019. Intraperitoneal delivery of acetate-encapsulated liposomal nanoparticles for neuroprotection of the penumbra in a rat model of ischemic stroke. Int. J. Nanomed 14:1979&#x2013;91</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6430000</ArticleId><ArticleId IdType="pubmed">30936698</ArticleId></ArticleIdList></Reference><Reference><Citation>Polania Gutierrez JJ, Munakomi S. 2021. Intramuscular Injection. Treasure Island, FL: StatPearls Publ.</Citation><ArticleIdList><ArticleId IdType="pubmed">32310581</ArticleId></ArticleIdList></Reference><Reference><Citation>Davies N, Hovdal D, Edmunds N, Nordberg P, Dahlen A, et al. 2021. Functionalized lipid nanoparticles for subcutaneous administration of mRNA to achieve systemic exposures of a therapeutic protein. Mol. Ther. Nucleic Acids 24:369&#x2013;84</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8039535</ArticleId><ArticleId IdType="pubmed">33868782</ArticleId></ArticleIdList></Reference><Reference><Citation>Al-Ghobashy MA, ElMeshad AN, Abdelsalam RM, Nooh MM, Al-Shorbagy M, Laible G. 2017. Development and pre-clinical evaluation of recombinant human myelin basic protein nano therapeutic vaccine in experimental autoimmune encephalomyelitis mice animal model. Sci. Rep 7:46468.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5397842</ArticleId><ArticleId IdType="pubmed">28425447</ArticleId></ArticleIdList></Reference><Reference><Citation>Shyam R, Ren Y, Lee J, Braunstein KE, Mao HQ, Wong PC. 2015. Intraventricular delivery of siRNA nanoparticles to the central nervous system. Mol. Ther. Nucleic Acids 4:e242.</Citation><ArticleIdList><ArticleId IdType="pubmed">25965552</ArticleId></ArticleIdList></Reference><Reference><Citation>Tarumi T, Yamabe T, Fukuie M, Zhu DC, Zhang R, et al. 2021. Brain blood and cerebrospinal fluid flow dynamics during rhythmic handgrip exercise in young healthy men and women. J. Physiol 599:1799&#x2013;813</Citation><ArticleIdList><ArticleId IdType="pubmed">33481257</ArticleId></ArticleIdList></Reference><Reference><Citation>Helakari H, Korhonen V, Holst S, Piispala J, Kallio M, et al. 2020. Sleep-specific changes in physiological brain pulsations. bioRxiv. 10.1101/2020.09.03.280479</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2020.09.03.280479</ArticleId></ArticleIdList></Reference><Reference><Citation>Stanton EH, Persson NDA, Gomolka RS, Lilius T, Sigurethsson B, et al. 2021. Mapping of CSF transport using high spatiotemporal resolution dynamic contrast-enhanced MRI in mice: effect of anesthesia. Magn. Reson. Med 85:3326&#x2013;42</Citation><ArticleIdList><ArticleId IdType="pubmed">33426699</ArticleId></ArticleIdList></Reference><Reference><Citation>Plog BA, Mestre H, Olveda GE, Sweeney AM, Kenney HM, et al. 2018. Transcranial optical imaging reveals a pathway for optimizing the delivery of immunotherapeutics to the brain. JCI Insight 3:e120922</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6237481</ArticleId><ArticleId IdType="pubmed">30333324</ArticleId></ArticleIdList></Reference><Reference><Citation>Christine CW, Starr PA, Larson PS, Eberling JL, Jagust WJ, et al. 2009. Safety and tolerability of putaminal AADC gene therapy for Parkinson disease. Neurology 73:1662&#x2013;69</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2839805</ArticleId><ArticleId IdType="pubmed">19828868</ArticleId></ArticleIdList></Reference><Reference><Citation>Kaplitt MG, Feigin A, Tang C, Fitzsimons HL, Mattis P, et al. 2007. Safety and tolerability of gene therapy with an adeno-associated virus (AAV) borne GAD gene for Parkinson&#x2019;s disease: an open label, phase I trial. Lancet 369:2097&#x2013;105</Citation><ArticleIdList><ArticleId IdType="pubmed">17586305</ArticleId></ArticleIdList></Reference><Reference><Citation>LeWitt PA, Rezai AR, Leehey MA, Ojemann SG, Flaherty AW, et al. 2011. AAV2-GAD gene therapy for advanced Parkinson&#x2019;s disease: a double-blind, sham-surgery controlled, randomised trial. Lancet Neurol. 10:309&#x2013;19</Citation><ArticleIdList><ArticleId IdType="pubmed">21419704</ArticleId></ArticleIdList></Reference><Reference><Citation>Bourdenx M, Daniel J, Genin E, Soria FN, Blanchard-Desce M, et al. 2016. Nanoparticles restore lysosomal acidification defects: implications for Parkinson and other lysosomal-related diseases. Autophagy 12:472&#x2013;83</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4835967</ArticleId><ArticleId IdType="pubmed">26761717</ArticleId></ArticleIdList></Reference><Reference><Citation>Abbasi S, Uchida S, Toh K, Tockary TA, Dirisala A, et al. 2021. Co-encapsulation of Cas9 mRNA and guide RNA in polyplex micelles enables genome editing in mouse brain. J. Control. Release 332:260&#x2013;68</Citation><ArticleIdList><ArticleId IdType="pubmed">33647431</ArticleId></ArticleIdList></Reference><Reference><Citation>Frey WH 2nd. 1991. Neurologic agents for nasal administration to the brain. WO Patent 1991/007947</Citation></Reference><Reference><Citation>Lombardo R, Musumeci T, Carbone C, Pignatello R. 2021. Nanotechnologies for intranasal drug delivery: an update of literature. Pharm. Dev. Technol 26:824&#x2013;45</Citation><ArticleIdList><ArticleId IdType="pubmed">34218736</ArticleId></ArticleIdList></Reference><Reference><Citation>Tang S, Wang A, Yan X, Chu L, Yang X, et al. 2019. Brain-targeted intranasal delivery of dopamine with borneol and lactoferrin co-modified nanoparticles for treating Parkinson&#x2019;s disease. Drug Deliv. 26:700&#x2013;7</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7577045</ArticleId><ArticleId IdType="pubmed">31290705</ArticleId></ArticleIdList></Reference><Reference><Citation>Pu H, Ma C, Zhao Y, Wang Y, Zhang W, et al. 2021. Intranasal delivery of interleukin-4 attenuates chronic cognitive deficits via beneficial microglial responses in experimental traumatic brain injury. J. Cereb. Blood Flow Metab 41:2870&#x2013;86</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8545055</ArticleId><ArticleId IdType="pubmed">34259069</ArticleId></ArticleIdList></Reference><Reference><Citation>Chung K, Ullah I, Kim N, Lim J, Shin J, et al. 2020. Intranasal delivery of cancer-targeting doxorubicin-loaded PLGA nanoparticles arrests glioblastoma growth. J. Drug Target 28:617&#x2013;26</Citation><ArticleIdList><ArticleId IdType="pubmed">31852284</ArticleId></ArticleIdList></Reference><Reference><Citation>Erdo F, Bors LA, Farkas D, Bajza A, Gizurarson S. 2018. Evaluation of intranasal delivery route of drug administration for brain targeting. Brain Res. Bull 143:155&#x2013;70</Citation><ArticleIdList><ArticleId IdType="pubmed">30449731</ArticleId></ArticleIdList></Reference><Reference><Citation>Helmbrecht H, Joseph A, McKenna M, Zhang M, Nance E. 2020. Governing transport principles for nanotherapeutic application in the brain. Curr. Opin. Chem. Eng 30:112&#x2013;19</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7723339</ArticleId><ArticleId IdType="pubmed">33304774</ArticleId></ArticleIdList></Reference><Reference><Citation>Joseph A, Simo GM, Gao T, Alhindi N, Xu N, et al. 2021. Surfactants influence polymer nanoparticle fate within the brain. Biomaterials 277:121086.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8478896</ArticleId><ArticleId IdType="pubmed">34481289</ArticleId></ArticleIdList></Reference><Reference><Citation>Nance E, Zhang F, Mishra MK, Zhang Z, Kambhampati SP, et al. 2016. Nanoscale effects in dendrimer-mediated targeting of neuroinflammation. Biomaterials 101:96&#x2013;107</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5379995</ArticleId><ArticleId IdType="pubmed">27267631</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang M, Bishop BP, Thompson NL, Hildahl K, Dang B, et al. 2019. Quantum dot cellular uptake and toxicity in the developing brain: implications for use as imaging probes. Nanoscale Adv. 1:3424&#x2013;42</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6924642</ArticleId><ArticleId IdType="pubmed">31867563</ArticleId></ArticleIdList></Reference><Reference><Citation>Nance EA, Woodworth GF, Sailor KA, Shih TY, Xu Q, et al. 2012. A dense poly(ethylene glycol) coating improves penetration of large polymeric nanoparticles within brain tissue. Sci. Transl. Med 4:149ra19</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3718558</ArticleId><ArticleId IdType="pubmed">22932224</ArticleId></ArticleIdList></Reference><Reference><Citation>Godin AG, Varela JA, Gao Z, Danne N, Dupuis JP, et al. 2017. Single-nanotube tracking reveals the nanoscale organization of the extracellular space in the live brain. Nat. Nanotechnol 12:238&#x2013;43</Citation><ArticleIdList><ArticleId IdType="pubmed">27870840</ArticleId></ArticleIdList></Reference><Reference><Citation>Thorne RG, Nicholson C. 2006. In vivo diffusion analysis with quantum dots and dextrans predicts the width of brain extracellular space. PNAS 103:5567&#x2013;72</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1459394</ArticleId><ArticleId IdType="pubmed">16567637</ArticleId></ArticleIdList></Reference><Reference><Citation>Amani H, Arzaghi H, Bayandori M, Dezfuli AS, Pazoki-Toroudi H, et al. 2019. Controlling cell behavior through the design of biomaterial surfaces: a focus on surface modification techniques. Adv. Mater. Interfaces 6:1900572</Citation></Reference><Reference><Citation>Modena MM, R&#xfc;hle B, Burg TP, Wuttke S. 2019. Nanoparticle characterization: What to measure? Adv. Mater 31:1901556</Citation><ArticleIdList><ArticleId IdType="pubmed">31148285</ArticleId></ArticleIdList></Reference><Reference><Citation>Brown TD, Habibi N, Wu D, Lahann J, Mitragotri S. 2020. Effect of nanoparticle composition, size, shape, and stiffness on penetration across the blood-brain barrier. ACS Biomater. Sci. Eng 6:4916&#x2013;28</Citation><ArticleIdList><ArticleId IdType="pubmed">33455287</ArticleId></ArticleIdList></Reference><Reference><Citation>Curtis C, Toghani D, Wong B, Nance E. 2018. Colloidal stability as a determinant of nanoparticle behavior in the brain. Colloids Surf. B 170:673&#x2013;82</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6664798</ArticleId><ArticleId IdType="pubmed">29986264</ArticleId></ArticleIdList></Reference><Reference><Citation>van Rooy I, Cakir-Tascioglu S, Hennink WE, Storm G, Schiffelers RM, Mastrobattista E. 2011. In vivo methods to study uptake of nanoparticles into the brain. Pharm. Res 28:456&#x2013;71</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3044085</ArticleId><ArticleId IdType="pubmed">20924653</ArticleId></ArticleIdList></Reference><Reference><Citation>Bickel U 2005. How to measure drug transport across the blood-brain barrier. NeuroRx 2:15&#x2013;26</Citation><ArticleIdList><ArticleId IdType="pmc">PMC539317</ArticleId><ArticleId IdType="pubmed">15717054</ArticleId></ArticleIdList></Reference><Reference><Citation>Alqahtani F, Chowdhury EA, Bhattacharya R, Noorani B, Mehvar R, Bickel U. 2018. Brain uptake of [13C] and [14C]sucrose quantified by microdialysis and whole tissue analysis in mice. Drug Metab. Dispos 46:1514&#x2013;18</Citation><ArticleIdList><ArticleId IdType="pubmed">30115645</ArticleId></ArticleIdList></Reference><Reference><Citation>Collins JM, Dedrick RL. 1983. Distributed model for drug delivery to CSF and brain tissue. Am. J. Physiol 245:R303&#x2013;10</Citation><ArticleIdList><ArticleId IdType="pubmed">6614201</ArticleId></ArticleIdList></Reference><Reference><Citation>Miller HA, Magsam AW, Tarudji AW, Romanova S, Weber L, et al. 2019. Evaluating differential nanoparticle accumulation and retention kinetics in a mouse model of traumatic brain injury via Ktrans mapping with MRI. Sci. Rep 9:16099.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6834577</ArticleId><ArticleId IdType="pubmed">31695100</ArticleId></ArticleIdList></Reference><Reference><Citation>Houston ZH, Bunt J, Chen KS, Puttick S, Howard CB, et al. 2020. Understanding the uptake of nanomedicines at different stages of brain cancer using a modular nanocarrier platform and precision bispecific antibodies. ACS Cent. Sci 6:727&#x2013;38</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7256936</ArticleId><ArticleId IdType="pubmed">32490189</ArticleId></ArticleIdList></Reference><Reference><Citation>Smith QR, Allen DD. 2003. In situ brain perfusion technique. Methods Mol. Med 89:209&#x2013;18</Citation><ArticleIdList><ArticleId IdType="pubmed">12958422</ArticleId></ArticleIdList></Reference><Reference><Citation>Takasato Y, Rapoport SI, Smith QR. 1984. An in situ brain perfusion technique to study cerebrovascular transport in the rat. Am. J. Physiol 247:H484&#x2013;93</Citation><ArticleIdList><ArticleId IdType="pubmed">6476141</ArticleId></ArticleIdList></Reference><Reference><Citation>Cheng R, Zhang F, Li M, Wo X, Su YW, Wang W. 2019. Influence of fixation and permeabilization on the mass density of single cells: a surface plasmon resonance imaging study. Front. Chem 7:588.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6716545</ArticleId><ArticleId IdType="pubmed">31508410</ArticleId></ArticleIdList></Reference><Reference><Citation>Shepherd TM, Thelwall PE, Stanisz GJ, Blackband SJ. 2009. Aldehyde fixative solutions alter the water relaxation and diffusion properties of nervous tissue. Magn. Reson. Med 62:26&#x2013;34</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3188415</ArticleId><ArticleId IdType="pubmed">19353660</ArticleId></ArticleIdList></Reference><Reference><Citation>Tosi G, Duskey JT, Kreuter J. 2020. Nanoparticles as carriers for drug delivery of macromolecules across the blood-brain barrier. Expert Opin. Drug Deliv 17:23&#x2013;32</Citation><ArticleIdList><ArticleId IdType="pubmed">31774000</ArticleId></ArticleIdList></Reference><Reference><Citation>Thangudu S, Cheng FY, Su CH. 2020. Advancements in the blood-brain barrier penetrating nanoplat-forms for brain related disease diagnostics and therapeutic applications. Polymers 12:3055</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7766280</ArticleId><ArticleId IdType="pubmed">33419339</ArticleId></ArticleIdList></Reference><Reference><Citation>Terstappen GC, Meyer AH, Bell RD, Zhang W. 2021. Strategies for delivering therapeutics across the blood-brain barrier. Nat. Rev. Drug Discov 20:362&#x2013;83</Citation><ArticleIdList><ArticleId IdType="pubmed">33649582</ArticleId></ArticleIdList></Reference><Reference><Citation>D&#x2019;Souza A, Dave KM, Stetler RA, Manickam DS. 2021. Targeting the blood-brain barrier for the delivery of stroke therapies. Adv. Drug Deliv. Rev 171:332&#x2013;51</Citation><ArticleIdList><ArticleId IdType="pubmed">33497734</ArticleId></ArticleIdList></Reference><Reference><Citation>Timbie KF, Mead BP, Price RJ. 2015. Drug and gene delivery across the blood-brain barrier with focused ultrasound. J. Control. Release 219:61&#x2013;75</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4656107</ArticleId><ArticleId IdType="pubmed">26362698</ArticleId></ArticleIdList></Reference><Reference><Citation>Saunders NR, Liddelow SA, Dziegielewska KM. 2012. Barrier mechanisms in the developing brain. Front. Pharmacol 3:46.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3314990</ArticleId><ArticleId IdType="pubmed">22479246</ArticleId></ArticleIdList></Reference><Reference><Citation>Ek CJ, Dziegielewska KM, Stolp H, Saunders NR. 2006. Functional effectiveness of the blood-brain barrier to small water-soluble molecules in developing and adult opossum (Monodelphis domestica). J. Comp. Neurol 496:13&#x2013;26</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2634607</ArticleId><ArticleId IdType="pubmed">16528724</ArticleId></ArticleIdList></Reference><Reference><Citation>Millen JW, Hess A. 1958. The blood-brain barrier: an experimental study with vital dyes. Brain 81:248&#x2013;57</Citation><ArticleIdList><ArticleId IdType="pubmed">13572696</ArticleId></ArticleIdList></Reference><Reference><Citation>Dobbing J 1961. The blood-brain barrier. Physiol. Rev 41:130&#x2013;88</Citation><ArticleIdList><ArticleId IdType="pubmed">13723231</ArticleId></ArticleIdList></Reference><Reference><Citation>Donahue S, Pappas GD. 1961. The fine structure of capillaries in the cerebral cortex of the rat at various stages of development. Am. J. Anat 108:331&#x2013;47</Citation><ArticleIdList><ArticleId IdType="pubmed">13887158</ArticleId></ArticleIdList></Reference><Reference><Citation>Saunders NR, Dreifuss JJ, Dziegielewska KM, Johansson PA, Habgood MD, et al. 2014. The rights and wrongs of blood-brain barrier permeability studies: a walk through 100 years of history. Front. Neurosci 8:404.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4267212</ArticleId><ArticleId IdType="pubmed">25565938</ArticleId></ArticleIdList></Reference><Reference><Citation>Penta P 1932. Sulla colorazione vitale del sistema nervosa negli centrale animali neonati. Riv. Neurol 5:62&#x2013;80</Citation></Reference><Reference><Citation>Stern L, Rapoport J, Lokschina E. 1929. Le fonctionnement de la barri&#xe8;re h&#xe9;mato-enc&#xe9;phalique chez les nouveau n&#xe9;s. CR Soc. Biol 100:231&#x2013;23</Citation></Reference><Reference><Citation>Moos T, Mollgard K. 1993. Cerebrovascular permeability to azo dyes and plasma proteins in rodents of different ages. Neuropathol. Appl. Neurobiol 19:120&#x2013;27</Citation><ArticleIdList><ArticleId IdType="pubmed">8316332</ArticleId></ArticleIdList></Reference><Reference><Citation>Weber CM, Clyne AM. 2021. Sex differences in the blood-brain barrier and neurodegenerative diseases. APL Bioeng. 5:011509.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7968933</ArticleId><ArticleId IdType="pubmed">33758788</ArticleId></ArticleIdList></Reference><Reference><Citation>Parrado-Fern&#xe1;ndez C, Blennow K, Hansson M, Leoni V, Cedazo-Minguez A, Bj&#xf6;rkhem I. 2018. Evidence for sex difference in the CSF/plasma albumin ratio in ~20 000 patients and 335 healthy volunteers. J. Cell. Mol. Med 22:5151&#x2013;54</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6156389</ArticleId><ArticleId IdType="pubmed">30054982</ArticleId></ArticleIdList></Reference><Reference><Citation>Moon Y, Lim C, Kim Y, Moon WJ. 2021. Sex-related differences in regional blood-brain barrier integrity in non-demented elderly subjects. Int. J. Mol. Sci 22:2860.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8001339</ArticleId><ArticleId IdType="pubmed">33799794</ArticleId></ArticleIdList></Reference><Reference><Citation>Wilson AC, Clemente L, Liu T, Bowen RL, Meethal SV, Atwood CS. 2008. Reproductive hormones regulate the selective permeability of the blood-brain barrier. Biochim. Biophys. Acta 1782:401&#x2013;7</Citation><ArticleIdList><ArticleId IdType="pubmed">18381207</ArticleId></ArticleIdList></Reference><Reference><Citation>Cipolla MJ, Godfrey JA, Wiegman MJ. 2009. The effect of ovariectomy and estrogen on penetrating brain arterioles and blood-brain barrier permeability. Microcirculation 16:685&#x2013;93</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2857914</ArticleId><ArticleId IdType="pubmed">19905968</ArticleId></ArticleIdList></Reference><Reference><Citation>Robison LS, Gannon OJ, Salinero AE, Zuloaga KL. 2019. Contributions of sex to cerebrovascular function and pathology. Brain Res. 1710:43&#x2013;60</Citation><ArticleIdList><ArticleId IdType="pubmed">30580011</ArticleId></ArticleIdList></Reference><Reference><Citation>Kucharz K, Kristensen K, Johnsen KB, Lund MA, Lonstrup M, et al. 2021. Post-capillary venules are the key locus for transcytosis-mediated brain delivery of therapeutic nanoparticles. Nat. Commun 12:4121.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8257611</ArticleId><ArticleId IdType="pubmed">34226541</ArticleId></ArticleIdList></Reference><Reference><Citation>Nance E, Porambo M, Zhang F, Mishra MK, Buelow M, et al. 2015. Systemic dendrimer-drug treatment of ischemia-induced neonatal white matter injury. J. Control. Release 214:112&#x2013;20</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4732874</ArticleId><ArticleId IdType="pubmed">26184052</ArticleId></ArticleIdList></Reference><Reference><Citation>Kirschbaum K, Sonner JK, Zeller MW, Deumelandt K, Bode J, et al. 2016. In vivo nanoparticle imaging of innate immune cells can serve as a marker of disease severity in a model of multiple sclerosis. PNAS 113:13227&#x2013;32</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5135308</ArticleId><ArticleId IdType="pubmed">27799546</ArticleId></ArticleIdList></Reference><Reference><Citation>Shetty AK, Zanirati G. 2020. The interstitial system of the brain in health and disease. Aging Dis. 11:200&#x2013;11</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6961771</ArticleId><ArticleId IdType="pubmed">32010493</ArticleId></ArticleIdList></Reference><Reference><Citation>Hladky SB, Barrand MA. 2014. Mechanisms of fluid movement into, through and out of the brain: evaluation of the evidence. Fluids Barriers CNS 11:26.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4326185</ArticleId><ArticleId IdType="pubmed">25678956</ArticleId></ArticleIdList></Reference><Reference><Citation>Joseph A, Liao R, Zhang M, Helmbrecht H, McKenna M, et al. 2020. Nanoparticle-microglial interaction in the ischemic brain is modulated by injury duration and treatment. Bioeng. Transl. Med 5:e10175.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7510458</ArticleId><ArticleId IdType="pubmed">33005740</ArticleId></ArticleIdList></Reference><Reference><Citation>Iliff JJ, Wang M, Liao Y, Plogg BA, Peng W, et al. 2012. A paravascular pathway facilitates CSF flow through the brain parenchyma and the clearance of interstitial solutes, including amyloid beta. Sci. Transl. Med 4:147ra11</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3551275</ArticleId><ArticleId IdType="pubmed">22896675</ArticleId></ArticleIdList></Reference><Reference><Citation>Brinker T, Stopa E, Morrison J, Klinge P. 2014. A new look at cerebrospinal fluid circulation. Fluids Barriers CNS 11:10.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4016637</ArticleId><ArticleId IdType="pubmed">24817998</ArticleId></ArticleIdList></Reference><Reference><Citation>Kiviniemi V, Wang X, Korhonen V, Keinanen T, Tuovinen T, et al. 2016. Ultra-fast magnetic resonance encephalography of physiological brain activity&#x2014;glymphatic pulsation mechanisms? J. Cereb. Blood Flow Metab 36:1033&#x2013;45</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4908626</ArticleId><ArticleId IdType="pubmed">26690495</ArticleId></ArticleIdList></Reference><Reference><Citation>Eide PK, Vinje V, Pripp AH, Mardal KA, Ringstad G. 2021. Sleep deprivation impairs molecular clearance from the human brain. Brain 144:863&#x2013;74</Citation><ArticleIdList><ArticleId IdType="pubmed">33829232</ArticleId></ArticleIdList></Reference><Reference><Citation>Ringstad G, Valnes LM, Dale AM, Pripp AH, Vatnehol SS, et al. 2018. Brain-wide glymphatic enhancement and clearance in humans assessed with MRI. JCI Insight 3:e121537</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6124518</ArticleId><ArticleId IdType="pubmed">29997300</ArticleId></ArticleIdList></Reference><Reference><Citation>Sykova E, Nicholson C. 2008. Diffusion in brain extracellular space. Physiol. Rev 88:1277&#x2013;340</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2785730</ArticleId><ArticleId IdType="pubmed">18923183</ArticleId></ArticleIdList></Reference><Reference><Citation>Fenstermacher J, Kaye T. 1988. Drug &#x201c;diffusion&#x201d; within the brain. Ann. N.Y. Acad. Sci 531:29&#x2013;39</Citation><ArticleIdList><ArticleId IdType="pubmed">3382143</ArticleId></ArticleIdList></Reference><Reference><Citation>Pantazopoulos H, Berretta S. 2016. In sickness and in health: perineuronal nets and synaptic plasticity in psychiatric disorders. Neural Plast. 2016:9847696.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4709762</ArticleId><ArticleId IdType="pubmed">26839720</ArticleId></ArticleIdList></Reference><Reference><Citation>Wolak DJ, Thorne RG. 2013. Diffusion of macromolecules in the brain: implications for drug delivery. Mol. Pharm 10:1492&#x2013;504</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3646902</ArticleId><ArticleId IdType="pubmed">23298378</ArticleId></ArticleIdList></Reference><Reference><Citation>Wood T, Nance E. 2019. Disease-directed engineering for physiology-driven treatment interventions in neurological disorders. APL Bioeng. 3:040901.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6811362</ArticleId><ArticleId IdType="pubmed">31673672</ArticleId></ArticleIdList></Reference><Reference><Citation>Schwarz JM, Sholar PW, Bilbo SD. 2012. Sex differences in microglial colonization of the developing rat brain. J. Neurochem 120:948&#x2013;63</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3296888</ArticleId><ArticleId IdType="pubmed">22182318</ArticleId></ArticleIdList></Reference><Reference><Citation>Hanamsagar R, Bilbo SD. 2016. Sex differences in neurodevelopmental and neurodegenerative disorders: focus on microglial function and neuroinflammation during development. J. Steroid Biochem. Mol. Biol 160:127&#x2013;33</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4829467</ArticleId><ArticleId IdType="pubmed">26435451</ArticleId></ArticleIdList></Reference><Reference><Citation>McCullough LD, Zeng Z, Blizzard KK, Debchoudhury I, Hurn PD. 2005. Ischemic nitric oxide and poly (ADP-ribose) polymerase-1 in cerebral ischemia: male toxicity, female protection. J. Cereb. Blood Flow Metab 25:502&#x2013;12</Citation><ArticleIdList><ArticleId IdType="pubmed">15689952</ArticleId></ArticleIdList></Reference><Reference><Citation>Demarest TG, McCarthy MM. 2015. Sex differences in mitochondrial (dys)function: implications for neuroprotection. J. Bioenerg. Biomembr 47:173&#x2013;88</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4988325</ArticleId><ArticleId IdType="pubmed">25293493</ArticleId></ArticleIdList></Reference><Reference><Citation>Wickens MM, Bangasser DA, Briand LA. 2018. Sex differences in psychiatric disease: a focus on the glutamate system. Front. Mol. Neurosci 11:197.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5996114</ArticleId><ArticleId IdType="pubmed">29922129</ArticleId></ArticleIdList></Reference><Reference><Citation>Good M, Day M, Muir JL. 1999. Cyclical changes in endogenous levels of oestrogen modulate the induction of LTD and LTP in the hippocampal CA1 region. Eur. J. Neurosci 11:4476&#x2013;80</Citation><ArticleIdList><ArticleId IdType="pubmed">10594677</ArticleId></ArticleIdList></Reference><Reference><Citation>Warren SG, Humphreys AG, Juraska JM, Greenough WT. 1995. LTP varies across the estrous cycle: enhanced synaptic plasticity in proestrus rats. Brain Res. 703:26&#x2013;30</Citation><ArticleIdList><ArticleId IdType="pubmed">8719612</ArticleId></ArticleIdList></Reference><Reference><Citation>Hill CA, Fitch RH. 2012. Sex differences in mechanisms and outcome of neonatal hypoxia-ischemia in rodent models: implications for sex-specific neuroprotection in clinical neonatal practice. Neurol. Res. Int 2012:867531.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3306914</ArticleId><ArticleId IdType="pubmed">22474588</ArticleId></ArticleIdList></Reference><Reference><Citation>Prendergast BJ, Onishi KG, Zucker I. 2014. Female mice liberated for inclusion in neuroscience and biomedical research. Neurosci. Biobehav. Rev 40:1&#x2013;5</Citation><ArticleIdList><ArticleId IdType="pubmed">24456941</ArticleId></ArticleIdList></Reference><Reference><Citation>Benavente-Fern&#xe1;ndez I, Synnes A, Grunau RE, Chau V, Ramraj C, et al. 2019. Association of socioeconomic status and brain injury with neurodevelopmental outcomes of very preterm children. JAMA Netw. Open 2:e192914.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6503490</ArticleId><ArticleId IdType="pubmed">31050776</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim HJ, Magrane J, Starkov AA, Manfredi G. 2012. The mitochondrial calcium regulator cyclophilin D is an essential component of oestrogen-mediated neuroprotection in amyotrophic lateral sclerosis. Brain 135:2865&#x2013;74</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3437032</ArticleId><ArticleId IdType="pubmed">22961554</ArticleId></ArticleIdList></Reference><Reference><Citation>Minghetti L, Greco A, Zanardo V, Suppiej A. 2013. Early-life sex-dependent vulnerability to oxidative stress: the natural twining model. J. Matern. Fetal. Neonatal. Med 26:259&#x2013;62</Citation><ArticleIdList><ArticleId IdType="pubmed">23020682</ArticleId></ArticleIdList></Reference><Reference><Citation>Bayir H, Marion DW, Puccio AM, Wisniewski SR, Janesko KL, et al. 2004. Marked gender effect on lipid peroxidation after severe traumatic brain injury in adult patients. J. Neurotrauma 21:1&#x2013;8</Citation><ArticleIdList><ArticleId IdType="pubmed">14987460</ArticleId></ArticleIdList></Reference><Reference><Citation>Khalsa DS. 2015. Stress, meditation, and Alzheimer&#x2019;s disease prevention: where the evidence stands. J. Alzheimer&#x2019;s Dis 48:1&#x2013;12</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4923750</ArticleId><ArticleId IdType="pubmed">26445019</ArticleId></ArticleIdList></Reference><Reference><Citation>Helmbrecht H, Xu N, Liao R, Nance E. 2021. Data management schema design for effective nanoparticle formulation for neurotherapeutics. AIChE J. 67:e17459.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8993161</ArticleId><ArticleId IdType="pubmed">35399334</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>